| Title |
Doxycycline in the Coronavirus Disease 2019 Therapy
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, September 2021
|
| DOI | 10.2147/tcrm.s314923 |
| Pubmed ID | |
| Authors |
Karolina Dorobisz, Tadeusz Dorobisz, Dariusz Janczak, Tomasz Zatoński |
X Demographics
The data shown below were collected from the profiles of 84 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Kuwait | 7 | 8% |
| Saudi Arabia | 4 | 5% |
| France | 3 | 4% |
| United Arab Emirates | 2 | 2% |
| Libya | 2 | 2% |
| Spain | 1 | 1% |
| United Kingdom | 1 | 1% |
| Egypt | 1 | 1% |
| Iraq | 1 | 1% |
| Other | 1 | 1% |
| Unknown | 61 | 73% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 80 | 95% |
| Practitioners (doctors, other healthcare professionals) | 3 | 4% |
| Scientists | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 18 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 4 | 22% |
| Other | 2 | 11% |
| Researcher | 1 | 6% |
| Unknown | 11 | 61% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 17% |
| Nursing and Health Professions | 1 | 6% |
| Social Sciences | 1 | 6% |
| Psychology | 1 | 6% |
| Unknown | 12 | 67% |
Attention Score in Context
This research output has an Altmetric Attention Score of 69. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2024.
All research outputs
#630,137
of 25,722,279 outputs
Outputs from Therapeutics and Clinical Risk Management
#26
of 1,325 outputs
Outputs of similar age
#15,224
of 435,633 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 18 outputs
Altmetric has tracked 25,722,279 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,325 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.